Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tominaga, N.
Right arrow Articles by Yui, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tominaga, N.
Right arrow Articles by Yui, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 15, No. 1, pp. 1-10, January 2003
© 2003 Japanese Society for Immunology

Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4

Norio Tominaga1,2, Kozo Ohkusu-Tsukada1, Heiichiro Udono1, Ryo Abe4, Toshifumi Matsuyama3 and Katsuyuki Yui1

1 Division of Immunology, Department of Translational Medical Sciences, 2 Division of Medical Virology, and 3 Division of Cytokine Signaling, Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki University, Nagasaki 852-8523, Japan 4 Research Institute for Biological Sciences, Science University of Tokyo, 2669 Yamazaki, Noda, Chiba 278-0022, Japan

Correspondence to: K. Yui; E-mail: katsu{at}net.nagasaki-u.ac.jp
Transmitting editor: T. Saito

IFN-regulatory factor (IRF)-4 is a member of the IRF family of transcription factors expressed in lymphocytes and macrophages. The previous studies using mice deficient in the IRF-4 gene showed profound defects in function of both B and T cells. To further investigate the role of IRF-4 in CD4+ T cell function, IRF-4–/– mice were challenged with the intracellular pathogen Leishmania major. The mice were protected against L. major during the early phase of the infection and CD4+ T cells of the infected mice produced IFN-{gamma} in response to L. major antigen. However, during the late phase of infection, lymphocyte numbers were dramatically reduced in the draining lymph nodes, resulting in the deterioration of the lesion, indicating that IRF-4 was required for sustained immune responses against L. major infection. The function of CD4+ T cells was further investigated using TCR transgenic mice lacking the IRF-4 gene. CD4+ T cells from IRF-4–/– mice produced IFN-{gamma} and expressed T-bet after culture under Th1-skewing conditions in vitro. However, Th2 cell development was not observed after culture under Th2-polarizing conditions. Proliferation of CD4+ T cells to IL-4 was reduced in IRF-4–/– mice, suggesting the defects in the responsiveness to IL-4. Furthermore, stimulation of the IRF-4–/– CD4+ T cells with IL-4-induced activation of signal transducer and activator of transcription 6, but not expression of growth factor independent-1. Thus, development of CD4+ T cell subsets differentially depends on IRF-4; induction of Th1 response does not depend on IRF-4, while Th2 response depends entirely on IRF-4.

Keywords: IFN-{gamma}, IL-4, knockout mouse, Leishmania major


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Miyakoda, D. Kimura, M. Yuda, Y. Chinzei, Y. Shibata, K. Honma, and K. Yui
Malaria-Specific and Nonspecific Activation of CD8+ T Cells during Blood Stage of Plasmodium berghei Infection
J. Immunol., July 15, 2008; 181(2): 1420 - 1428.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Adotevi, B. Vingert, L. Freyburger, P. Shrikant, Y.-C. Lone, F. Quintin-Colonna, N. Haicheur, M. Amessou, A. Herbelin, P. Langlade-Demoyen, et al.
B Subunit of Shiga Toxin-Based Vaccines Synergize with {alpha}-Galactosylceramide to Break Tolerance against Self Antigen and Elicit Antiviral Immunity
J. Immunol., September 1, 2007; 179(5): 3371 - 3379.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Yoshida, K. Yamamoto, T. Kohno, N. Hironaka, K. Yasui, C. Kojima, H. Mukae, J.-i. Kadota, S. Suzuki, K. Honma, et al.
Active repression of IFN regulatory factor-1-mediated transactivation by IFN regulatory factor-4
Int. Immunol., November 1, 2005; 17(11): 1463 - 1471.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Honma, H. Udono, T. Kohno, K. Yamamoto, A. Ogawa, T. Takemori, A. Kumatori, S. Suzuki, T. Matsuyama, and K. Yui
Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS
PNAS, November 1, 2005; 102(44): 16001 - 16006.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Tamura, P. Tailor, K. Yamaoka, H. J. Kong, H. Tsujimura, J. J. O'Shea, H. Singh, and K. Ozato
IFN Regulatory Factor-4 and -8 Govern Dendritic Cell Subset Development and Their Functional Diversity
J. Immunol., March 1, 2005; 174(5): 2573 - 2581.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Ohkusu-Tsukada, N. Tominaga, H. Udono, and K. Yui
Regulation of the Maintenance of Peripheral T-Cell Anergy by TAB1-Mediated p38{alpha} Activation
Mol. Cell. Biol., August 15, 2004; 24(16): 6957 - 6966.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Lohoff, H.-W. Mittrucker, A. Brustle, F. Sommer, B. Casper, M. Huber, D. A. Ferrick, G. S. Duncan, and T. W. Mak
Enhanced TCR-induced Apoptosis in Interferon Regulatory Factor 4-deficient CD4+ Th Cells
J. Exp. Med., July 19, 2004; 200(2): 247 - 253.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Suzuki, K. Honma, T. Matsuyama, K. Suzuki, K. Toriyama, I. Akitoyo, K. Yamamoto, T. Suematsu, M. Nakamura, K. Yui, et al.
From the Cover: Critical roles of interferon regulatory factor 4 in CD11bhighCD8{alpha}- dendritic cell development
PNAS, June 15, 2004; 101(24): 8981 - 8986.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A.-L. Pauleau, R. Rutschman, R. Lang, A. Pernis, S. S. Watowich, and P. J. Murray
Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression
J. Immunol., June 15, 2004; 172(12): 7565 - 7573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Lund, Z. Chen, J. Scheinin, and R. Lahesmaa
Early Target Genes of IL-12 and STAT4 Signaling in Th Cells
J. Immunol., June 1, 2004; 172(11): 6775 - 6782.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.